Alembic Pharmaceuticals Limited — Others, 15-05-2025: Copy of Newspaper Publication

Alembic Pharmaceuticals has reported the loss of an equity share certificate for 1,500 shares held by the late Shrihari Kute. Legal heirs have applied for a duplicate certificate, while the company has cautioned the public against transacting in these shares. Shareholders with claims are urged to submit relevant documents to the company or Registrar and Transfer Agent promptly. If no claims arise within the specified period, the company will proceed with issuing the duplicate certificate, closing the window for any future claims on the original shares.